| Name |
Lian Liu |
| Title |
Professor, Chief Physician, Master Advisor |
| Areas of Focus |
Chemotherapy, targeted therapy, immunotherapy-based comprehensive treatment of various malignant tumors |
Lian Liu, Doctor of Hematological Oncology, Shandong University, Postdoctoral in Immunology, Chief Physician of Chemotherapy Department of Shandong University Qilu Hospital; Professor of Clinical Medicine, Shandong University, Doctoral Tutor of Oncology; Distinguished Young Talents of Qilu Hospital of Shandong University. Mainly engaged in the diagnosis and treatment of various malignant tumors, specializing in the diagnosis and comprehensive treatment of lung cancer, stomach cancer, intestinal cancer, and other malignant tumors. He is also the chairman of the Shandong Immunological Society's Tumor Molecular Marker and Targeted Therapy Professional Committee, the National Member of the Youth Committee of the Cancer Branch of the Chinese Medical Doctor Association, the Chinese Society of Clinical Oncology (CSCO) Immunotherapy, Nutrition Support Therapy, Thyroid Cancer Expert Committee, China Anti-Cancer Member of the Internal Medicine Group of the Society for Gastric Cancer Professional Committee (CGCA), member of the Standing Committee of the Chinese Society of Medical Education for difficult tumors, director of the Shandong Society of Immunology, deputy director of the Youth Committee of the Palliative Medicine Branch of the Shandong Medical Association, member of the Chemotherapy Branch of the Shandong Anti-Cancer Association, and Youth Committee Standing Committee Member, Deputy Chairman of the Cell Therapy Standards and Technology Committee of Shandong Medical Biotechnology Society, Deputy Chairman of the Shandong Pain Medicine Association Tumor Integrated Medical Specialty Committee, Standing Committee Member of the Shandong Medical Association Cancer Precision Medicine Branch, Shandong Geriatric Society Targeted Therapy Standing member of the professional committee, standing member of the MDT Special Committee of Shandong Medical Association, etc. In recent years, he has presided over 2 National Natural Science Funds, more than 10 other national, provincial and ministerial funds, and more than 1 million research funds. He has published 18 SCI papers with a total impact factor of more than 100 and more than 230 citations. He has independently trained more than ten postgraduates, and seven have graduated. At present, he concurrently serves as the National Natural Science Foundation of China Communications Evaluation Committee, the National Food and Drug Administration New Drug Evaluation Center Data Inspector, Shandong Province, Zhejiang Province, and Beijing Natural Science Foundation Final Evaluation Expert, and reviewer of many SCI journals. He was rated as a scientific research model and outstanding Communist Party member of Qilu Hospital of Shandong University.
Outpatient time:
Wednesday afternoon and Friday morning (immunotherapy specialist clinic).
Email:
